and 50 adults not using either medication. Study groups were matched by age, duration of diabetes, sex, BMI and HbA1c at baseline. HbA1c declined at 1 year by 0.68 percentage points in the ...

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

Eli Lilly’s Mounjaro has launched in India. Approved by CDSCO, it promises significant weight loss and blood sugar control. However, concerns remain over certain side effects.

The rising prevalence of prediabetes among young adults signals early metabolic dysfunction, significantly increasing the ...

High-protein diets enhance glycaemic control in Type 2 diabetes, with mycoprotein-rich vegan and omnivorous options showing ...

Continuing our series highlighting recent presentations from Nursing in Practice 365 events, diabetes specialist midwife ...

India is home to more than 100 million diabetics, and the demand for anti-diabetic drugs is on the rise -- the Rs 20,611 ...

Dental teams could soon detect early signs of undiagnosed Type-2 diabetes as part of routine appointments.

Ginger is a versatile spice that provides health benefits and is safe for most people to consume daily. Here are its benefits ...

The topic of diabetes will be the focus of the next Dinner with the Docs at 6 p.m. March 24 at the Grand Pointe Conference Center, 1500 Grand Central Ave., Vienna. “Connecting the Dots: the Impact of ...

Supplement companies that make green tea extract promote weight-loss claims, but also that their pills, powders, and potions ...

Novo Nordisk’s Wegovy (semaglutide) and Eli Lilly’s Zepbound (tirzepatide) quickly reached blockbuster status within their ...